Daunomycin and hypoxia Patient Reports February 11, 2012

Daunomycin Side Effects Report #4738588-3
Daunomycin side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 08, 2005. Male patient, weighting 187.4 lb, was diagnosed with acute myeloid leukaemia and was treated with Daunomycin. After drug was administered, patient experienced the following side effects: hypoxia, lung infiltration, pneumonitis. Daunomycin dosage: unknown. During the same period patient was treated with CYTARABINE, CYCLOSPORINE. Patient was hospitalized. Patient recovered.

Daunomycin Side Effects Report #4633176-1
Daunomycin side effect was reported by a Consumer or non-health professional from on Apr 11, 2005. Male patient, weighting 180.8 lb, was diagnosed with acute lymphocytic leukaemia and was treated with Daunomycin. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, agitation, apnoea, hypermetabolism, hypoxia, lung infiltration, mental status changes, metabolic disorder , pyrexia. Daunomycin dosage: 60 MG/M2 IVP ON DAYS 1, 8, 15, AND 22. During the same period patient was treated with VINCRISTINE SULPHATE, PREDNISONE, ELSPAR, METHOTREXATE. Patient recovered.

Daunomycin Side Effects Report #4652123-X
Daunomycin side effect was reported by a Consumer or non-health professional from on May 02, 2005. Male patient, weighting 180.8 lb, was diagnosed with acute lymphocytic leukaemia and was treated with Daunomycin. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, agitation, ammonia increased, apnoea, haemodialysis, hypermetabolism, hypoxia, mental status changes, pyrexia. Daunomycin dosage: 60 MG/M2 IVP ON DAYS 1, 8, 15, AND 22. During the same period patient was treated with VINCRISTINE SULPHATE, PREDNISONE, METHOTREXATE. Patient recovered.